Literature DB >> 17889276

A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.

Loïc Feuvret1, Georges Noel, Damien C Weber, Pascal Pommier, Regis Ferrand, Ludovic De Marzi, Frederic Dhermain, Claire Alapetite, Hamid Mammar, Gilbert Boisserie, Jean-Louis Habrand, Jean-Jacques Mazeron.   

Abstract

PURPOSE: To compare treatment planning between combined photon-proton planning (CP) and proton planning (PP) for skull base tumors, so as to assess the potential limitations of CP for these tumors. METHODS AND MATERIALS: Plans for 10 patients were computed for both CP and PP. Prescribed dose was 67 cobalt Gray equivalent (CGE) for PP; 45 Gy (photons) and 22 CGE (protons) for CP. Dose-volume histograms (DVHs) were calculated for gross target volume (GTV), clinical target volume (CTV), normal tissues (NT), and organs at risk (OARs) for each plan. Results were analyzed using DVH parameters, inhomogeneity coefficient (IC), and conformity index (CI).
RESULTS: Mean doses delivered to the GTVs and CTVs with CP (65.0 and 61.7 CGE) and PP (65.3 and 62.2 Gy CGE) were not significantly different (p > 0.1 and p = 0.72). However, the dose inhomogeneity was drastically increased with CP, with a mean significant incremental IC value of 10.5% and CP of 6.8%, for both the GTV (p = 0.01) and CTV (p = 0.04), respectively. The CI(80%) values for the GTV and CTV were significantly higher with PP compared with CP. Compared with CP, the use of protons only led to a significant reduction of NT and OAR irradiation, in the intermediate-to-low dose (< or =80% isodose line) range.
CONCLUSIONS: These results suggest that the use of CP results in levels of target dose conformation similar to those with PP. Use of PP significantly reduced the tumor dose inhomogeneity and the delivered intermediate-to-low dose to NT and OARs, leading us to conclude that this treatment is mainly appropriate for tumors in children.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889276     DOI: 10.1016/j.ijrobp.2007.07.2326

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

Review 1.  Chordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patients.

Authors:  Muneyoshi Yasuda; Damien Bresson; Salvatore Chibbaro; Jan F Cornelius; Marc Polivka; Loic Feuvret; Masakazu Takayasu; Bernard George
Journal:  Neurosurg Rev       Date:  2011-08-24       Impact factor: 3.042

2.  Use of gEUD for predicting ear and pituitary gland damage following proton and photon radiation therapy.

Authors:  L De Marzi; L Feuvret; T Boulé; J-L Habrand; F Martin; V Calugaru; N Fournier-Bidoz; R Ferrand; A Mazal
Journal:  Br J Radiol       Date:  2015-02-11       Impact factor: 3.039

3.  Carbon ion radiotherapy for skull base chordoma.

Authors:  Jun-Etsu Mizoe; Azusa Hasegawa; Ryo Takagi; Hiroki Bessho; Takeshi Onda; Hirohiko Tsujii
Journal:  Skull Base       Date:  2009-05

Review 4.  Proton therapy in chordoma of the base of the skull: a systematic review.

Authors:  Maurizio Amichetti; Marco Cianchetti; Dante Amelio; Riccardo Maurizi Enrici; Giuseppe Minniti
Journal:  Neurosurg Rev       Date:  2009-03-25       Impact factor: 3.042

Review 5.  Past, present, and future of radiotherapy for the benefit of patients.

Authors:  Juliette Thariat; Jean-Michel Hannoun-Levi; Arthur Sun Myint; Te Vuong; Jean-Pierre Gérard
Journal:  Nat Rev Clin Oncol       Date:  2012-11-27       Impact factor: 66.675

6.  Converging paths to progress for skull base chordoma: Review of current therapy and future molecular targets.

Authors:  Salvatore Di Maio; Esther Kong; Stephen Yip; Robert Rostomily
Journal:  Surg Neurol Int       Date:  2013-06-01

Review 7.  Novel targeted therapies in chordoma: an update.

Authors:  Salvatore Di Maio; Stephen Yip; Gmaan A Al Zhrani; Fahad E Alotaibi; Abdulrahman Al Turki; Esther Kong; Robert C Rostomily
Journal:  Ther Clin Risk Manag       Date:  2015-05-26       Impact factor: 2.423

8.  Initial clinical experience with scanned proton beams at the Italian National Center for Hadrontherapy (CNAO).

Authors:  J Tuan; B Vischioni; P Fossati; A Srivastava; V Vitolo; A Iannalfi; M R Fiore; M Krengli; J E Mizoe; R Orecchia
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

9.  Three discipline collaborative radiation therapy (3DCRT) special debate: The United States should build additional proton therapy facilities.

Authors:  Steve Braunstein; Li Wang; Wayne Newhauser; Todd Tenenholz; Yi Rong; Albert van der Kogel; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-02-08       Impact factor: 2.102

10.  The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT.

Authors:  A Gutierrez; V Rompokos; K Li; C Gillies; D D'Souza; F Solda; N Fersht; Y-C Chang; G Royle; R A Amos; T Underwood
Journal:  Acta Oncol       Date:  2019-08-20       Impact factor: 4.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.